<DOC>
	<DOCNO>NCT00003933</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , genetic testing , may improve ability detect acute lymphocytic leukemia determine extent disease . PURPOSE : Diagnostic study try detect change gene child treat relapsed acute lymphocytic leukemia .</brief_summary>
	<brief_title>Diagnostic Study Gene Alterations Children Who Have Been Treated Relapsed Acute Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine incidence p16/p15 homozygous deletion p15 promoter hypermethylation acute lymphocytic leukemia cell child treat protocol CCG-1941 . - Determine prognostic importance p16/p15 abnormalities child . - Determine presence absence p16/p15 abnormality dominant clone diagnosis present relapse patient . OUTLINE : Frozen cell obtain sample collect protocol CCG-1941 . DNA isolate examine use Southern blot analysis assay deletion promoter hypermethylation p16 and/or p15 . PROJECTED ACCRUAL : Approximately 100 sample obtain study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphocytic leukemia treat protocol CCG1941 Material cryopreserved CCG cell bank PATIENT CHARACTERISTICS : Age : Children Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
</DOC>